A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.

Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada ...

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...

In a major policy reversal, the Trump administration has ordered the CDC to cease all scientific research involving primates, accelerating its effort to end animal testing.

Galapagos offers deep value with €3B cash, a focused M&A strategy, and new leadership. Click here to read an analysis of GLPG ...

MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from ...

A fatty diet doesn’t just damage the liver — it rewires its cells in ways that give cancer a dangerous head start.

With 2025 entering the rearview mirror, Reminder Publishing is taking a look back at some of the biggest stories in ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...

In recovery from methamphetamine and with a mind toward starting anew, Ambrose Haynes spent six months on housing waitlists.

A new WHO strategy aims to ensure innovations align with policy priorities and reach vulnerable groups, Belgium's 'unmet patient needs' expertise will be 'foundational' ...